Probiotics in the Management of Ulcerative Colitis

Por Fedorak, Richard N.
Publicado em 2010

Probiotic Therapies for IBD

Por Fedorak, Richard N.
Publicado em 2007

Exercise and inflammatory bowel disease

Por Narula, Neeraj, Fedorak, Richard N
Publicado em 2008

Does smoking reduce infliximab’s effectiveness against Crohn’s disease?

Por Narula, Neeraj, Fedorak, Richard N
Publicado em 2009

Systematic review of stimulant and nonstimulant laxatives for the treatment of functional constipation

Por Paré, Pierre, Fedorak, Richard N
Publicado no Can J Gastroenterol Hepatol (2014)

Probiotics in the Management of Inflammatory Bowel Disease

Por Penner, Robert M., Fedorak, Richard N.
Publicado em 2005

Predicting, treating and preventing postoperative recurrence of Crohn’s disease: The state of the field

Por Borowiec, Anna M, Fedorak, Richard N
Publicado em 2011

Gastric intramural hematoma: A case report and literature review

Por Dhawan, Vivek, Mohamed, Ahmed, Fedorak, Richard N
Publicado em 2009

Canadian Digestive Health Foundation Public Impact Series. Inflammatory bowel disease in Canada: Incidence, prevalence, and direct and indirect economic impact

Por Fedorak, Richard N, Wong, Karen, Bridges, Ron
Publicado em 2010

Oropharyngeal Crohn’s disease

Por Mohamed, Rachid, Schultz, Robert, Fedorak, Richard N
Publicado em 2008

Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn’s disease

Por Ma, Christopher, Walters, Brennan, Fedorak, Richard N
Publicado em 2013

Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature

Por Verma, Sanam, Kroeker, Karen I, Fedorak, Richard N
Publicado em 2013

Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease

Por Bernard, Edmond-Jean, Fedorak, Richard N., Jairath, Vipul
Publicado no Dig Dis Sci (2020)

Canadian Digestive Health Foundation Public Impact Series: Gastroesophageal reflux disease in Canada: Incidence, prevalence, and direct and indirect economic impact

Por Fedorak, Richard N, van Zanten, Sander Veldhuyzen, Bridges, Ron
Publicado em 2010

Canadian Digestive Health Foundation Public Impact Series 5: Pancreatitis in Canada. Incidence, prevalence, and direct and indirect economic impact

Por Teshima, Christopher W, Bridges, Ronald J, Fedorak, Richard N
Publicado em 2012

Canadian Digestive Health Foundation Public Impact Series 4: Celiac disease in Canada. Incidence, prevalence, and direct and indirect economic impact

Por Fedorak, Richard N, Switzer, Connie M, Bridges, Ron J
Publicado em 2012

Distance management of inflammatory bowel disease: Systematic review and meta-analysis

Por Huang, Vivian W, Reich, Krista M, Fedorak, Richard N
Publicado em 2014

Clinicians’ guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease

Por Bressler, Brian, Panaccione, Remo, Fedorak, Richard N, Seidman, Ernest G
Publicado no Can J Gastroenterol Hepatol (2015)

Increased risk of colorectal cancer in ulcerative colitis patients diagnosed after 40 years of age

Por Karvellas, Constantine J, Fedorak, Richard N, Hanson, John, Wong, Clarence KW
Publicado em 2007

A Machine-Learned Predictor of Colonic Polyps Based on Urinary Metabolomics

Por Eisner, Roman, Greiner, Russell, Tso, Victor, Wang, Haili, Fedorak, Richard N.
Publicado em 2013